Russell E. Byrns - Concepedia

Author

Russell E. Byrns

University of California, Los Angeles

Also Known As

Russell Byrns, Russell E Byrns, Russell E. Byrns

Publications

Citations

H-Index

Concepts

All Affiliations

University of California, Los Angeles University of Naples Federico II Oklahoma State University Center for Health Sciences University of Sannio Massachusetts General Hospital

About

Russell E. Byrns is an author at University of California, Los Angeles specializing in medicine, vascular biology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	844
2	Health Sciences	3	3	285
3	Engineering	1	1	144
4	Natural Sciences	1	1	144
5	Biochemistry	1	1	170

Russell E. Byrns

Publications

Citations

H-Index

Page 1

	Year	Citations
Vascular smooth muscle-derived relaxing factor (MDRF) and its close similarity to nitric oxide K S Wood, Georgette M. Buga, Russell E. Byrns, Biochemical and Biophysical Research Communications Muscle-derived Relaxing FactorReactive Nitrogen SpecieNitric OxideMedicinePhysiology	1990	179
Pomegranate juice protects nitric oxide against oxidative destruction and enhances the biological actions of nitric oxide Louis J. Ignarro, Russell E. Byrns, Daigo Sumi, Nitric Oxide Food ChemistryHealth SciencesBiochemistryPomegranate Juice ProtectsNitric Oxide	2006	170
California Hass Avocado: Profiling of Carotenoids, Tocopherol, Fatty Acid, and Fat Content during Maturation and from Different Growing Areas Qing‐Yi Lu, Yue Wang, David Wang, Journal of Agricultural and Food Chemistry NutritionEngineeringBotanyAgricultural EconomicsRipening	2009	144
NG-Amino-L-arginine: A new potent antagonist of L-arginine-mediated endothelium-dependent relaxation Jon M. Fukuto, K S Wood, Russell E. Byrns, Biochemical and Biophysical Research Communications New Potent AntagonistMedicineVascular PharmacologyVascular BiologyPharmacotherapy	1990	71
Beneficial effects of concurrent autologous bone marrow cell therapy and metabolic intervention in ischemia-induced angiogenesis in the mouse hindlimb Claudio Napoli, Sharon Williams‐Ignarro, Filomena de Nigris, Proceedings of the National Academy of Sciences Mouse HindlimbImmunologyBmc TherapyOxidative StressRegenerative Medicine	2005	70
Nebivolol: a selective β1-adrenergic receptor antagonist that relaxes vascular smooth muscle by nitric oxide- and cyclic GMP-dependent mechanisms Louis J. Ignarro, Russell E. Byrns, Kim Trinh, Nitric Oxide Molecular PharmacologyMedicineVascular PharmacologyPhysiologyCyclic Gmp-dependent Mechanisms	2002	68
L-Arginine causes whereas L-argininosuccinic acid inhibits endothelium-dependent vascular smooth muscle relaxation Michele E. Gold, K S Wood, Georgette M. Buga, Biochemical and Biophysical Research Communications MedicineVascular PharmacologyPhysiologyEndothelial DysfunctionVascular Biology	1989	63
Loss of endothelium-dependent vasodilatation and nitric oxide release after myocardial protection with University of Wisconsin solution Jeffrey M. Pearl, Hillel Laks, Davis C. Drinkwater, Journal of Thoracic and Cardiovascular Surgery Cardiovascular DiseaseNitric Oxide ReleaseVascular PharmacologyPhysiologyEndothelial Dysfunction	1994	63
Physical training and metabolic supplementation reduce spontaneous atherosclerotic plaque rupture and prolong survival in hypercholesterolemic mice Claudio Napoli, Sharon Williams‐Ignarro, Filomena de Nigris, Proceedings of the National Academy of Sciences	2006	54
Therapeutic Effects of Autologous Bone Marrow Cells and Metabolic Intervention in the Ischemic Hindlimb of Spontaneously Hypertensive Rats Involve Reduced Cell Senescence and CXCR4/Akt/eNOS Pathways Filomena de Nigris, Maria Luisa Balestrieri, Sharon Williams‐Ignarro, Journal of Cardiovascular Pharmacology HypertensionNitric OxideImmunologyCxcr4/akt/enos PathwaysRat Model	2007	45

Page 1